{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:55:02Z","timestamp":1776124502605,"version":"3.50.1"},"reference-count":33,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Cholangiocarcinoma (CCA) is a malignancy that originates from the biliary epithelium, presenting either intrahepatically or extrahepatically. A late-stage diagnosis and a poor overall prognosis characterise it. D-dimer, a biomarker indicative of coagulation and fibrinolysis activation, is believed to play a significant role in cancer progression, with elevated plasma levels correlating positively with metastatic disease and advanced cancer stages. In intrahepatic CCA, fibrinogen has been identified as an independent prognostic factor associated with adverse outcomes and reflects systemic inflammatory responses. The increased expression of urokinase-type plasminogen activator has been linked to lymphatic invasion and metastatic spread in CCA patients. Additionally, a preoperative elevation in prothrombin time may predict reduced survival rates for individuals undergoing potentially curative surgical interventions. P-selectin, which interacts predominantly with leukocyte ligands, has the potential to promote tumourigenesis and facilitate metastatic dissemination of mucin-producing carcinomas. Moreover, prolonged activated partial thromboplastin time may provide valuable insights into the extent of parenchymal involvement in CCA. This review aims to elucidate the role of coagulation abnormalities within the pathophysiology of cholangiocarcinoma.<\/jats:p>","DOI":"10.5937\/jomb0-56538","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:21:30Z","timestamp":1761816090000},"page":"237-244","source":"Crossref","is-referenced-by-count":1,"title":["Role of coagulation irregularities in cholangiocarcinoma: A review"],"prefix":"10.5937","volume":"45","author":[{"given":"Hafsa","family":"Hamid","sequence":"first","affiliation":[{"name":"Lahore College for Women University, Department of Biotechnology, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sladjana","family":"Coric","sequence":"additional","affiliation":[{"name":"Clinical Centre of Montenegro, Department of Cardiology, Podgorica, Montenegro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Rafaqa","sequence":"additional","affiliation":[{"name":"Lahore College for Women University, Department of Zoology (Molecular Physiology and Endocrinology), Lahore, Punjab, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9230-9093","authenticated-orcid":false,"given":"Sanja","family":"Gluscevic","sequence":"additional","affiliation":[{"name":"Clinical Centre of Montenegro, Department of Neurology, Podgorica, Montenegro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filiz","family":"Mercantepe","sequence":"additional","affiliation":[{"name":"Recep Tayyip Erdogan University, Faculty of Medicine, Department of Endocrinology and Metabolism, Rize, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-0996","authenticated-orcid":false,"given":"Aleksandra","family":"Klisic","sequence":"additional","affiliation":[{"name":"University of Montenegro, Faculty of Medicine, Podgorica, Montenegro"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015; 29(2): 221-32. doi: 10.1016\/j.bpg.2015.02.003;","DOI":"10.1016\/j.bpg.2015.02.003"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM. Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer 2013; 119(22): 3929-42. doi: 10.1002\/cncr.28312;","DOI":"10.1002\/cncr.28312"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 2016; 13(5): 261-80. doi: 10.1038\/nrgastro.2016.51;","DOI":"10.1038\/nrgastro.2016.51"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 60(6): 1268-89. doi: 10.1016\/j.jhep.2014.01.021;","DOI":"10.1016\/j.jhep.2014.01.021"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Yoh T, Hatano E, Nishio T, Seo S, Taura K, Yasuchika K, et al. Significant improvement in outcomes of patients with intrahepatic cholangiocarcinoma after surgery. World J Surg 2016; 40(9): 2229-36. doi: 10.1007\/s00268-016-3583-1;","DOI":"10.1007\/s00268-016-3583-1"},{"key":"ref6","unstructured":"Ruzzenente A, Conci S, Valdegamberi A, Pedrazzani C, Guglielmi A. Role of surgery in the treatment of intrahepatic cholangiocarcinoma. Eur Rev Med Pharmacol Sci 2015; 19(15): 2892-900;"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Wang H, Liu W, Tian M, Tang Z, Jiang X, Zhou P, et al. Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection. Biosci Trends 2017; 11(4): 469-74. doi: 10.5582\/bst.2017.01080;","DOI":"10.5582\/bst.2017.01080"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wang HS, Ge XX, Li QP, Nie JJ, Miao L. Clinical significance of prothrombin time in cholangiocarcinoma patients with surgeries. Can J Gastroenterol Hepatol 2019; 2019: 3413969. doi: 10.1155\/2019\/3413969;","DOI":"10.1155\/2019\/3413969"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ke X, Jin B, You W, Chen Y, Xu H, Zhao H, et al. Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer. BMC Cancer 2021; 21(1): 953. doi: 10.1186\/s12885-021-08684-w;","DOI":"10.1186\/s12885-021-08684-w"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Johnson ED, Schell JC, Rodgers GM. The D-dimer assay. Am J Hematol 2019; 94(7): 833-39. doi: 10.1002\/ajh.25482;","DOI":"10.1002\/ajh.25482"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Chen Q, Zheng Y, Zhao H, Cai J, Wang L, Zhao J, Bi X, Li Z, Huang Z, Zhang Y, Zhou J, Wu J. The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection. Ann Transl Med 2020; 8(5): 192. doi: 10.21037\/atm.2020.01.72;","DOI":"10.21037\/atm.2020.01.72"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Dai H, Zhou H, Sun Y, Xu Z, Wang S, Feng T, Zhang P. D-dimer as a potential clinical marker for predicting metastasis and progression in cancer. Biomed Rep 2018; 9(5): 453-57. doi: 10.3892\/br.2018.1151;","DOI":"10.3892\/br.2018.1151"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Watanabe A, Araki K, Hirai K, Kubo N, Igarashi T, Tsukagoshi M, et al. A novel clinical factor, D-dimer platelet multiplication, may predict postoperative recurrence and prognosis for patients with cholangiocarcinoma. Ann Surg Oncol 2016; 23(Suppl 5): 886-91. doi: 10.1245\/s10434-016-5422-x;","DOI":"10.1245\/s10434-016-5422-x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Reinhart WH. Fibrinogen-marker or mediator of vascular disease? Vasc Med 2003; 8(3): 211-6. doi: 10.1191\/1358863x03vm494ra;","DOI":"10.1191\/1358863x03vm494ra"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Rafaqat S, Gluscevic S, Patoulias D, Sharif S, Klisic A. The association between coagulation and atrial fibrillation. Biomedicines 2024; 12: 274. doi: 10.3390\/biomedicines12020274;","DOI":"10.3390\/biomedicines12020274"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Azam A, Klisic A, Mercantepe F, Faseeh H, Mercantepe T, Rafaqat S. Role of coagulation factors in hepatocellular carcinoma: A literature review. Life 2025; 15(1): 34. doi: 10.3390\/life15010034;","DOI":"10.3390\/life15010034"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci 2001; 936: 406-25;","DOI":"10.1111\/j.1749-6632.2001.tb03525.x"},{"key":"ref18","unstructured":"Zhang C, Wang H, Ning Z, Xu L, Zhuang L, et al. Hyperfibrinogen is associated with the systemic inflammatory response and predicts poor prognosis in intrahepatic cholangiocarcinoma. Int J Clin Exp Med 2017; 10: 5670-77;"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Li S, Zhang X, Lou C, Gu Y, Zhao J. Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma. Front Oncol 2022; 12: 1003845. doi: 10.3389\/fonc.2022.1003845;","DOI":"10.3389\/fonc.2022.1003845"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Liu H, Qiu G, Hu F, Wu H. Fibrinogen\/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection. World J Surg Oncol 2021; 19(1): 218. doi: 10.1186\/s12957-021-02330-2;","DOI":"10.1186\/s12957-021-02330-2"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zeng L, Tang Y, Huang X, Pei W, Liao Y, Liu J. Combined impact of prognostic nutritional index, fibrinogen-to-albumin ratio, and neutrophil-to-lymphocyte ratio on surgical outcomes and prognosis in hepatocellular carcinoma. Am J Cancer Res 2025; 15(2): 439-51. doi: 10.62347\/RTMF3105;","DOI":"10.62347\/RTMF3105"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Xu J, Li S, Feng Y, Zhang J, Peng Y, Wang X, Wang H. The fibrinogen\/albumin ratio index as an independent prognostic biomarker for patients with combined hepatocellular cholangiocarcinoma after surgery. Cancer Manag Res 2022; 14: 1795-1806. doi: 10.2147\/CMAR.S361462;","DOI":"10.2147\/CMAR.S361462"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Mahmood N, Mihalcioiu C, Rabbani SA. Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): Diagnostic, prognostic, and therapeutic applications. Front Oncol 2018; 8: 24. doi: 10.3389\/fonc.2018.00024;","DOI":"10.3389\/fonc.2018.00024"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhai BT, Tian H, Sun J, Zou JB, Zhang XF, Cheng JX, Shi YJ, Fan Y, Guo DY. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer. J Transl Med 2022; 20(1): 135. doi: 10.1186\/s12967-022-03329-3;","DOI":"10.1186\/s12967-022-03329-3"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Grunnet M, Christensen IJ, Lassen U, Jensen LH, Lydolph M, Lund IK, Thurison T, H\u00f8yer-Hansen G, Mau-S\u00f8rensen M. Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. Clin Biochem 2014; 47(7-8): 599-604. doi: 10.1016\/j.clinbiochem.2014.01.030;","DOI":"10.1016\/j.clinbiochem.2014.01.030"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Thummarati P, Wijitburaphat S, Prasopthum A, Menakongka A, Sripa B, Tohtong R, Suthiphongchai T. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis. World J Gastroenterol 2012; 18(3): 244-50. doi: 10.3748\/wjg.v18.i3.244;","DOI":"10.3748\/wjg.v18.i3.244"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Hu MD, Jia LH, Wang ML. PLAU contributes to the development of cholangiocarcinoma via activating NF-\u03baB signaling pathway. Cell Biol Int 2023; 47(8): 1381-91. doi: 10.1002\/cbin.12025;","DOI":"10.1002\/cbin.12025"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21(3): 131-42. doi: 10.1016\/j.blre.2006.11.001;","DOI":"10.1016\/j.blre.2006.11.001"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Golubeva MG. Role of P-Selectin in the development of hemostasis disorders in COVID-19. Biol Bull Rev 2022; 12: 406-13;","DOI":"10.1134\/S207908642204003X"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A 1998; 95(16): 9325-30. doi: 10.1073\/pnas.95.16.9325;","DOI":"10.1073\/pnas.95.16.9325"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Su MC, Hsu C, Kao HL, Jeng YM. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 2006; 235(1): 34-9. doi: 10.1016\/j.canlet.2005.03.059;","DOI":"10.1016\/j.canlet.2005.03.059"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Morrissey JH. Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol 2004; 79(2): 103-8. doi: 10.1532\/ijh97.03167;","DOI":"10.1532\/IJH97.03167"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Wiwanitkit V. Activated partial thromboplastin time abnormality in patients with cholangiocarcinoma. Clin Appl Thromb Hemost 2004; 10(1): 69-71. doi: 10.1177\/107602960401000112;","DOI":"10.1177\/107602960401000112"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Uloga poreme\u0107aja koagulacije kod holangiokarcinoma - pregled"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/56538\/29200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582602237H.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:44:32Z","timestamp":1772225072000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582602237H"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-56538","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}